摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-羟基-6-甲基-[1,4]苯醌 | 2446-75-5

中文名称
2-羟基-6-甲基-[1,4]苯醌
中文别名
——
英文名称
2-Hydroxy-6-methyl-benzochinon
英文别名
6-Hydroxy-toluchinon;3-Hydroxy-2.5-toluchinon;2-Hydroxy-6-methylcyclohexa-2,5-diene-1,4-dione
2-羟基-6-甲基-[1,4]苯醌化学式
CAS
2446-75-5
化学式
C7H6O3
mdl
——
分子量
138.123
InChiKey
OUSQDTMHWCQLAU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    126 °C(Solv: benzene (71-43-2))
  • 沸点:
    250.7±40.0 °C(Predicted)
  • 密度:
    1.395±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:9aa4848f0a14083818be0a324a2fc470
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] CYSTATHIONINE-Upsilon-LYASE (CSE) INHIBITORS<br/>[FR] INHIBITEURS DE LA CYSTATHIONINE- Gamma -LYASE (CSE)
    申请人:SOVA PHARMACEUTICALS INC
    公开号:WO2014018570A1
    公开(公告)日:2014-01-30
    Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine -γ-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.
    本文描述了一些化合物和含有这些化合物的药物组合物,这些化合物抑制半胱氨酸-γ-裂解酶(CSE)。本文还描述了使用这些CSE抑制剂的方法,单独或与其他化合物结合,用于治疗需要CSE抑制的疾病或病况。
  • Thiele acetylation of substituted benzoquinones
    作者:H. S. Wilgus、J. W. Gates,Jr
    DOI:10.1139/v67-314
    日期:1967.9.1

    The treatment of substituted quinones with acetic anhydride under acid catalysis gives substituted triacetoxybenzenes. Previous work on this reaction is summarized, and the reaction has been extended to include quinones having electron-withdrawing groups, and two quinones which had previously been reported as inactive.

    用醋酸酐在酸催化下处理取代醌可得到取代三乙酰氧基苯。对这种反应的先前研究进行了总结,并将该反应扩展到包括具有电子吸引基团的醌,以及之前被报道为不活跃的两种醌。
  • Rust disease control by Aphanocladium album and/or Beauveria brongniartii
    申请人:Subbiah Ven
    公开号:US20070110726A1
    公开(公告)日:2007-05-17
    There is disclosed a method and composition for controlling rust disease in plants. Metabolites produced by Aphanocladium album mycoparasites are recovered and applied in an effective amount to plants at risk for acquiring rust disease More specifically, the application of the metabolite converts infective urediniospores that cause rust disease into non-infective teliospores. In a more specific aspect, the metabolite is reacted with another substance or under a specific reaction to result in a different compound which is also effective against rust disease.
    本发明揭示了一种用于控制植物锈病的方法和组合物。通过Aphanocladium album真菌寄生体产生的代谢物被提取并以有效量施用于有患锈病风险的植物上。更具体地,代谢物的施用将导致引起锈病的传染性锈子孢子转变为非传染性的子囊孢子。在更具体的方面,这种代谢物与另一种物质或在特定反应条件下反应,形成对锈病也有效的不同化合物。
  • HETEROARYL INHIBITORS OF PDE4
    申请人:Tetra Discovery Partners, LLC
    公开号:US20150119362A1
    公开(公告)日:2015-04-30
    The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of disease.
    本发明涉及化合物和方法,用于作为磷酸二酯酶4(PDE4)的抑制剂,用于治疗或预防疾病。
  • CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS
    申请人:SOVA PHARMACEUTICALS, INC.
    公开号:US20150175561A1
    公开(公告)日:2015-06-25
    Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-γ-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.
    本文描述了一些抑制半胱氨酸-γ-裂解酶(CSE)的化合物和含有这些化合物的药物组合物。本文还描述了使用这些CSE抑制剂的方法,单独或与其他化合物结合,用于治疗需要CSE抑制的疾病或病症。
查看更多